Wasatch Advisors’s Apyx Medical APYX Stock Holding History

Wasatch Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-200,000	Closed	-$718K	–	346
2016 Q4	$718K	Sell	200,000 -100,000	-33%	-$446K	0.01%	320
2016 Q3	$1.56M	Sell	300,000 -40,000	-12%	-$130K	0.02%	280
2016 Q2	$558K	Hold	340,000	–	–	0.01%	342
2016 Q1	$602K	Sell	340,000 -100,000	-23%	-$201K	0.01%	340
2015 Q4	$924K	Buy	440,000 +100,000	+29%	+$193K	0.01%	337
2015 Q3	$673K	Buy	340,000 +40,000	+13%	+$91.7K	0.01%	341
2015 Q2	$837K	Hold	300,000	–	–	0.01%	350
2015 Q1	$717K	Buy	+300,000	New	+$998K	0.01%	356

Other funds holding APYX

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return